Jordana Ray-Kirton

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 5 papers. Top paper: “Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation”.

Multi-omic analysis of lung tumors defines pathways activated in neuroendocrine transformation

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.12.02.408476

N/A

0DataRank · unranked

24 citations

Hirozaku Taniguchi, Yingqian A. Zhan, Maysun Hasan, Fanli Meng, Fathema Uddin +23 more

Multiomic Analysis of Lung Tumors Defines Pathways Activated in Neuroendocrine Transformation

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1863

N/A

0DataRank · unranked

181 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +31 more

Comprehensive molecular characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation

Journal of Hematology & Oncology(2021)10.1186/s13045-021-01186-z

N/A

0DataRank · unranked

93 citations

Hirokazu Taniguchi, Yingqian A. Zhan, Maysun Hasan, Shweta S. Chavan, Fanli Meng +25 more

Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

Cancer Research(2021)10.1158/0008-5472.can-21-2964

N/A

0DataRank · unranked

49 citations

Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Shweta S. Chavan +21 more

Data from Inhibition of XPO1 Sensitizes Small Cell Lung Cancer to First- and Second-Line Chemotherapy

(2023)10.1158/0008-5472.c.6513732.v1

N/A

0DataRank · unranked

0 citations

Hirokazu Taniguchi, Yuan Hao, Andrew Chow, Yingqian A. Zhan, Shweta S. Chavan +21 more